Sales rise 11.54% to Rs 257.72 crore
Net profit of Suven Pharmaceuticals rose 3.33% to Rs 82.21 crore in the quarter ended September 2024 as against Rs 79.56 crore during the previous quarter ended September 2023. Sales rose 11.54% to Rs 257.72 crore in the quarter ended September 2024 as against Rs 231.05 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var.Sales257.72231.05 12 OPM %40.3642.40 -PBDT116.46117.30 -1 PBT99.50105.41 -6 NP82.2179.56 3Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
